News
Medical chatbot firm OpenEvidence raises $210m
OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research.
News
EVERSANA unveils new AI-powered pharmacovigilance suite
EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.
Digital
Digital twins and virtual trials: A new era in rare disease ...
Integrating digital twins and virtual trials with AI in clinical research will usher in a new era of drug development for rare diseases.
News
Four AIs for spinal fractures can be used by NHS, says NICE
AIs that detect spinal fractures during routine CT scans could help the NHS reduce hip fractures and other costly complications, says NICE.
Digital
From pilots to impact: What it really takes to scale GenAI i...
It’s no longer about what GenAI can do. It’s about what it should do – and whether it can consistently deliver value at scale.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
